All companies › BNTX

BNTX · BioNTech SE

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells4
Research cases0
Last filing2026-10-09

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-10-06 — Sahin Ugur · sold 21,000 @ $96.81 2026-10-07 — Sahin Ugur · sold 24,000 @ $95.86 2026-10-08 — Sahin Ugur · sold 27,000 @ $92.31 2026-10-09 — Sahin Ugur · sold 36,209 @ $95.37
2026-10-062026-10-09

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Sahin Ugur Chief Executive Officer, 10% owner
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $BNTX is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-10-09', 'insider_name': 'Sahin Ugur', 'insider_title': 'Chief Executive Officer, 10% owner', 'transaction_type': 'Open-market sell', 'shares': 36209.0, 'price': 95.3733, 'value': 3453371.82, 'is_buy': False}, {'transaction_date': '2026-10-08', 'insider_name': 'Sahin Ugur', 'insider_title': 'Chief Executive Officer, 10% owner', 'transaction_type': 'Open-market sell', 'shares': 27000.0, 'price': 92.3142, 'value': 2492483.4, 'is_buy': False}, {'transaction_date': '2026-10-07', 'insider_name': 'Sahin Ugur', 'insider_title': 'Chief Executive Officer, 10% owner', 'transaction_type': 'Open-market sell', 'shares': 24000.0, 'price': 95.8597, 'value': 2300632.8, 'is_buy': False}, {'transaction_date': '2026-10-06', 'insider_name': 'Sahin Ugur', 'insider_title': 'Chief Executive Officer, 10% owner', 'transaction_type': 'Open-market sell', 'shares': 21000.0, 'price': 96.8093, 'value': 2032995.3, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for BNTX today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.